Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04928001 · ClinicalTrials.gov registry record · NA

Implementing and Evaluating an Internet-based Cognitive Behavior Therapy Intervention in School Settings

A NA study, sponsored by Montana State University.

Completed
Registry status
NA
Development phase
67
Enrollment target

NCT04928001: Completed NA study, sponsored by Montana State University.

NCT04928001 is a NA study that has completed, run by Montana State University. The registered enrollment target is 67 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04928001, a NA study, has completed, sponsored by Montana State University.

COMPLETED
Registry status
NA
Development phase
67 participants
Enrollment target

Study Summary

This research study examines rural youth's experience of an internet based cognitive behavioral therapy intervention, and their experience of symptoms of depression, anxiety and co-occurring disorders.

Primary Outcome

The inventory measures anxiety symptoms and utilizes T Scores. 52.45 indicates the population mean with a standard deviation of 11.4 55 or less minimal, average symptoms of anxiety 55-59 mild symptoms of anxiety 60-69 moderate symptoms of anxiety 70+ severe symptoms of anxiety

Interventions

  • OTHER internet based iCBT program, Youth Thrive

Trial Details

FieldValue
Enrollment Target 67 participants
Start Date 2021-02-17
Est. Completion 2021-04-09
Phase NA
Montana State University

36 total trials

What the finished NCT04928001 record still lists

NCT04928001 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 67 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).

The record links to 0 conditions, and to 1 intervention - of which internet based iCBT program, Youth Thrive is the first listed.

NCT04928001 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04928001 about?

NCT04928001 is a clinical study titled "Implementing and Evaluating an Internet-based Cognitive Behavior Therapy Intervention in School Settings". This research study examines rural youth's experience of an internet based cognitive behavioral therapy intervention, and their experience of symptoms of depression, anxiety and co-occurring disorders.

What is the current status of trial NCT04928001?

This trial is currently completed. It is a NA study. The enrollment target is 67 participants. The study started on 2021-02-17. Estimated completion is 2021-04-09.

What interventions are being tested in trial NCT04928001?

The interventions under investigation include: internet based iCBT program, Youth Thrive (OTHER).

Who is sponsoring clinical trial NCT04928001?

This trial is sponsored by Montana State University, which has 36 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04928001's enrollment target sits among peer trials

67 1139th of 2000 higher than 862 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03213002 · 67 participants · Phase 1

    Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM

  • NCT04115163 · 67 participants · Phase 2

    Biologically Optimized Infusion Schedule of Gemcitabine and Nab-Paclitaxel for the Treatment of Metastatic Pancreatic Cancer

  • NCT04315324 · 67 participants · Phase 1

    Study to Test OBI-3424 in Patients With T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LBL)

  • NCT04532424 · 67 participants · NA

    Transcranial Magnetic Stimulation for Restricted and Repetitive Behavior in ASD

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04928001, the US trial registry maintained by the National Library of Medicine. NCT04928001 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.